Results 51 to 60 of about 37,370 (230)
CA125: Holy Grail or a Poisoned Chalice [PDF]
Nephron Clinical Practice, 2005 The history of (and perhaps the lessons to be learned from) peritoneal CA125 investigation presents no better example of the diffi culties in assigning the status of a ‘marker’ predictive of membrane dysfunction to factors measured in dialysis effl uent. In 1995, Visser et al. [3] were the fi rst to suggest that CA125 could be used as ‘a bulk marker of
Nicholas, Topley +2 more
openaire +2 more sources
BMEMat, EarlyView.LSPR biosensing enables rapid, sensitive, and low‐sample‐volume detection of biomarkers, with broad applications in diagnosing cancer, infectious, and chronic diseases. Advances in nanostructure design, micro/nanofabrication, and microfluidic integration have expanded the potential of LSPR sensors in biomedical diagnostics.
Zhaoxin Geng +4 more
wiley +1 more source
The Value of CA125 and CA19-9 in the Diagnosis of Stage Ⅲ and Ⅳ Endometriosis
Clinical and Experimental Obstetrics & GynecologyBackground: To evaluate the effect of carbohydrate antigen 125 (CA125) and CA19-9 in distinguishing stage Ⅲ and Ⅳ endometriosis from benign and malignant tumors, and to explore whether it is related to the clinical features of the disease.
Wenwen Zhang +4 more
doaj +1 more source
Biomarkers of lung congestion and injury in acute heart failure
ESC Heart Failure, Volume 12, Issue 2, Page 781-789, April 2025.Abstract Acute heart failure (AHF) classification and management are primarily based on lung congestion and/or hypoperfusion. The quantification of the vascular and tissue lung damage is not standard practice though biomarkers of lung injury may play a relevant role in this context.
Marco Guazzi +9 more
wiley +1 more source
, 2016 Aim of the study was to assess statistical differences of serum levels of HE4 and CA125 between certain endometrial cancer stages, grading and histological types. Material and methods : A retrospective study of 52 patients admitted to our clinic for a
Anna Słomka +5 more
core +1 more source
Screening anti-MSLN antibodies for binding to MUC16/CA125.
, 2023 Antibodies were screened via ELISA for binding to immobilized MSLN and MUC16/CA125 proteins. Human serum albumin (HSA) was used as negative control. Panel A shows that the antibody referred to herein as NAV-001 was the only antibody from the group that ...
J. Bradford Kline (4415671) +2 more
core +1 more source
Сибирский онкологический журнал, 2022 Purpose of the study: to assess the relationship between atypical/hybrid forms of EpCAM+CD45+ cells in ascitic fluid of ovarian cancer patients and the levels of cancer markers, such as CA125 and HE4, and the tumor grade. Material and methods.
A. V. Kozik +4 more
doaj +1 more source
Illuminating point‐of‐care diagnostics with aggregation‐induced emission biosensors
FlexMat, EarlyView.This review highlights the application of aggregation‐induced emission luminogens (AIEgens) in point‐of‐care (POC) diagnostics for disease biomarker detection. It systematically examines a range of biosensing platforms, including lateral flow immunoassays, microfluidic chips, and electrochemiluminescence sensors, alongside their utility in detecting ...
Danni Hu +3 more
wiley +1 more source
Ovarian Fibroma with Meigs Syndrome associated with Elevated CA125 - A Rare Case [PDF]
, 2010 Postmenopausal women with solid adnexal masses, ascites and pleural effusion with elevated CA 125 are highly suggestive for malignant ovarian tumor. However in literature 28 cases Meigs syndrome (Benign ovarian tumor, ascites and right pleural effusion ...
Gnana Prakash, S +3 more
core
Clinical evaluation of serum CA125 levels in gynecological disease patients [PDF]
, 1986 Since Bast et. al. reported that patients with ovarian carcinoma had elevated levels of CA125 in serum, the attention has been paid to CA125 in serum as a tumor maker. Serum CA125 levels in 88 patients with gynecological disease were measured.
Hiraki, Yoshio +19 more
core +1 more source